HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Pierre Bassand Selected Research

Enoxaparin (Lovenox)

2/2010Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience.
3/2009Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes.
3/2009Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.
10/2007Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
9/2007Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes.
6/2006Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
4/2006Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
12/2005Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes.
4/2002Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Pierre Bassand Research Topics

Disease

30Acute Coronary Syndrome
01/2020 - 07/2002
28Hemorrhage
01/2022 - 04/2002
25Stroke (Strokes)
01/2022 - 04/2006
24Atrial Fibrillation
01/2022 - 01/2012
22Myocardial Infarction
03/2014 - 04/2002
13Thrombosis (Thrombus)
03/2014 - 03/2003
9ST Elevation Myocardial Infarction
11/2010 - 04/2002
8Embolism (Embolus)
01/2022 - 10/2009
4Ischemia
03/2009 - 12/2005
4Unstable Angina
12/2005 - 01/2003
3Vascular Diseases (Vascular Disease)
02/2021 - 12/2019
3Heart Failure
02/2021 - 12/2019
3Hypertension (High Blood Pressure)
02/2021 - 01/2006
3Infarction (Infarctions)
11/2011 - 03/2003
3Pulmonary Embolism
10/2009 - 08/2003
2Thromboembolism
02/2021 - 12/2019
2Diabetes Mellitus
02/2021 - 12/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 12/2019
2Body Weight (Weight, Body)
08/2013 - 04/2006
2Rupture
02/2013 - 03/2003
2Stable Angina
10/2009 - 11/2007
2Type 2 Diabetes Mellitus (MODY)
12/2006 - 01/2006
2Hypercholesterolemia
12/2006 - 09/2004
2Cardiovascular Diseases (Cardiovascular Disease)
12/2006 - 01/2006
2Venous Thrombosis (Deep-Vein Thrombosis)
12/2005 - 03/2005
1Kidney Diseases (Kidney Disease)
01/2019
1Cardiomyopathies (Cardiomyopathy)
01/2019
1Chronic Renal Insufficiency
01/2019
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2012
1Shock
10/2009
1Cardiogenic Shock
10/2009
1Syncope (Fainting)
10/2009
1Albuminuria
02/2009
1Venous Thromboembolism
11/2007
1Coronary Disease (Coronary Heart Disease)
12/2006
1Atherosclerosis
12/2006

Drug/Important Bio-Agent (IBA)

30AnticoagulantsIBA
01/2022 - 11/2002
15Fondaparinux (Arixtra)FDA Link
02/2010 - 03/2005
9Enoxaparin (Lovenox)FDA LinkGeneric
02/2010 - 04/2002
8Vitamin KFDA Link
02/2021 - 03/2012
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2014 - 12/2008
5Factor Xa InhibitorsIBA
02/2021 - 03/2005
5ThrombinFDA Link
03/2014 - 03/2005
5Clopidogrel (Plavix)FDA Link
08/2013 - 07/2002
5Heparin (Liquaemin)FDA LinkGeneric
11/2008 - 01/2003
4AntithrombinsIBA
02/2021 - 04/2002
4Factor Xa (Coagulation Factor Xa)IBA
07/2013 - 03/2005
4TroponinIBA
10/2009 - 03/2003
3Fibrinolytic Agents (Antithrombotic Agents)IBA
02/2013 - 02/2008
3Pharmaceutical PreparationsIBA
10/2009 - 09/2004
2N(4)-oleylcytosine arabinosideIBA
02/2021 - 01/2019
2RivaroxabanIBA
07/2013 - 01/2012
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2012 - 04/2006
2C-Reactive ProteinIBA
02/2010 - 02/2009
2P-SelectinIBA
10/2009 - 11/2007
2Glycoproteins (Glycoprotein)IBA
10/2009 - 11/2007
2MetalsIBA
10/2009 - 11/2007
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2009 - 01/2003
2Biological ProductsIBA
02/2009 - 02/2009
2Glucose (Dextrose)FDA LinkGeneric
02/2009 - 01/2006
2LDL CholesterolIBA
12/2006 - 01/2006
2A-factor (Streptomyces)IBA
04/2006 - 12/2005
2Abciximab (ReoPro)FDA Link
12/2005 - 08/2002
2Tirofiban (Aggrastat)FDA Link
12/2005 - 08/2002
1Prasugrel HydrochlorideFDA Link
08/2013
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2013
1Warfarin (Coumadin)FDA LinkGeneric
03/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2011
1trichostatin A (A 300)IBA
09/2010
1Fibrinogen (Factor I)FDA Link
10/2009
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2009
1Prothrombin (Factor II)IBA
10/2009
1Thromboplastin (Tissue Factor)IBA
10/2009
1Plasminogen InactivatorsIBA
10/2009
1Factor VIIa (Activated Factor VII)IBA
10/2009
1omega-Chloroacetophenone (Mace)IBA
04/2009
1CreatinineIBA
02/2009
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2009
1Brain Natriuretic Peptide (Natrecor)FDA Link
02/2009
1StreptokinaseFDA Link
02/2008
1bivalirudin (Angiomax)FDA Link
05/2007
1Adenosine Triphosphate (ATP)IBA
12/2006
1Lipoproteins (Lipoprotein)IBA
12/2006
1LipidsIBA
12/2006
1Atorvastatin (Lipitor)FDA Link
12/2006
1DEAE-Dextran (Pulsar)IBA
12/2006
1Rosuvastatin Calcium (Crestor)FDA Link
12/2006
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2006
1CholesterolIBA
12/2006
1oxidized low density lipoproteinIBA
12/2006

Therapy/Procedure

29Therapeutics
01/2021 - 04/2002
8Percutaneous Coronary Intervention
08/2011 - 01/2003
5Stents
07/2013 - 11/2007
3Thrombolytic Therapy
02/2008 - 08/2003
2Blood Transfusion (Blood Transfusions)
10/2009 - 05/2007
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2012
1Length of Stay
10/2009
1Contraindications
04/2009
1Conservative Treatment
11/2008
1Catheters
10/2007